Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-15

FDA Approved: RANOLAZINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ranolazine submitted by Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)